Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges

Cancer is one of the main causes of death worldwide. To date, and despite the advances in conventional treatment options, therapy in cancer is still far from optimal due to the non-specific systemic biodistribution of antitumor agents. The inadequate drug concentrations at the tumor site led to an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Francisco, Caruana, Pablo, De la Fuente, Noa, Español, Pía, Gámez, María, Balart, Josep, Llurba, Elisa, Rovira, Ramón, Ruiz, Raúl, Martín-Lorente, Cristina, Corchero, José Luis, Céspedes, María Virtudes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221343/
https://www.ncbi.nlm.nih.gov/pubmed/35740909
http://dx.doi.org/10.3390/biom12060784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221343/
https://www.ncbi.nlm.nih.gov/pubmed/35740909
http://dx.doi.org/10.3390/biom12060784

Ejemplares similares